Tetra's Opioid Pain Alternative Moving Closer to FDA Approval

Tetra Bio-Pharma announced that its investigational new drug involving cannabinoids, QIXLEEF, received guidance to strengthen its nonclinical and toxicological data from the U.S. Food and Drug Administration, which brings it closer to marketing approval.